Co-Diagnostics Inc [CODX] stock is trading at $0.28, up 5.07%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CODX shares have gain 9.37% over the last week, with a monthly amount glided 1.66%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Co-Diagnostics Inc [NASDAQ: CODX] stock has seen the most recent analyst activity on August 12, 2022, when Sidoti downgraded its rating to a Neutral but kept the price target unchanged to $5 for it. Previously, Sidoti started tracking the stock with Buy rating on December 29, 2021, and set its price target to $14. On March 29, 2021, downgrade downgraded it’s rating to Hold. Maxim Group upgraded its rating to a Buy. H.C. Wainwright reiterated its recommendation of a Buy and raised its price target to $35 on May 18, 2020. H.C. Wainwright reiterated a Buy rating for this stock on March 09, 2020, and upped its price target to $20. In a note dated March 03, 2020, Maxim Group downgraded an Hold rating on this stock.
Co-Diagnostics Inc [CODX] stock has fluctuated between $0.23 and $2.23 over the past year. Currently, Wall Street analysts expect the stock to reach $6 within the next 12 months. Co-Diagnostics Inc [NASDAQ: CODX] shares were valued at $0.28 at the most recent close of the market. An investor can expect a potential return of 2042.86% based on the average CODX price forecast.
Analyzing the CODX fundamentals
Co-Diagnostics Inc [NASDAQ:CODX] reported sales of 0.57M for the trailing twelve months, which represents a drop of -80.11%. Gross Profit Margin for this corporation currently stands at -0.12% with Operating Profit Margin at -40.79%, Pretax Profit Margin comes in at -35.75%, and Net Profit Margin reading is -35.79%. To continue investigating profitability, this company’s Return on Assets is posted at -0.65, Equity is -0.6 and Total Capital is -0.82. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.04.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, Co-Diagnostics Inc’s Current Ratio is 4.43. As well, the Quick Ratio is 4.23, while the Cash Ratio is 0.35. Considering the valuation of this stock, the price to sales ratio is 16.30, the price to book ratio is 0.19.
